참고문헌
- Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006;108: 2509-19. https://doi.org/10.1182/blood-2006-03-010777
- Killick SB, Marsh JC, Gordon-Smith EC, Sorlin L, Gibson FM. Effects of antithymocyte globulin on bone marrow CD34+ cells in aplastic anaemia and myelodysplasia. Br J Haematol 2000;108: 582-91. https://doi.org/10.1046/j.1365-2141.2000.01853.x
- Teramura M, Kobayashi S, Iwabe K, Yoshinaga K, Mizoguchi H. Mechanism of action of antithymocyte globulin in the treatment of aplastic anaemia: in vitro evidence for the presence of immunosuppressive mechanism. Br J Haematol 1997;96:80-4. https://doi.org/10.1046/j.1365-2141.1997.d01-1981.x
- Todd A, Todd J. Graves' disease following successful treatment of severe aplastic anaemia with antilymphocyte globulin. Clin Lab Haematol 1999;21:69-70. https://doi.org/10.1046/j.1365-2257.1999.00190.x
- Zomas A, Marsh JC, Harrison NK, Hyer SL, Nussey SS, Knee G, et al. Rapid progression of fibrosing alveolitis and thyrotoxicosis after antithymocyte globulin therapy for aplastic anemia. Ann Hematol 1995;71:49-51. https://doi.org/10.1007/BF01696232
- Hinterberger-Fischer M, Kier P, Forstinger I, Lechner K, Kornek G, Breyer S, et al. Coincidence of severe aplastic anaemia with multiple sclerosis or thyroid disorders: report of 5 cases. Acta Haematol 1994;92:136-9. https://doi.org/10.1159/000204203
- Kumar M, Goldman J. Severe aplastic anaemia and Grave's disease in a paediatric patient. Br J Haematol 2002;118:327-9. https://doi.org/10.1046/j.1365-2141.2002.03581.x
- Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, et al. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med 2011;365:430-8. https://doi.org/10.1056/NEJMoa1103975
- Ginsberg J. Diagnosis and management of Graves’ disease. Can Med Assoc J 2003;168:575-85.
- Volpe R. The immunoregulatory disturbance in autoimmune thyroid disease. Autoimmunity 1988;2:55-72. https://doi.org/10.3109/08916938809019943
-
Feng X, Kajigaya S, Solomou EE, Keyvanfar K, Xu X, Raghavachari N, et al. Rabbit ATG but not horse ATG promotes expansion of functional
$CD4+CD25^{high}FOXP3+$ regulatory T cells in vitro. Blood 2008;111:3675-83. https://doi.org/10.1182/blood-2008-01-130146 - Scheinberg P, Fischer SH, Li L, Nunez O, Wu CO, Sloand EM, et al. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood 2007;109:3219-24. https://doi.org/10.1182/blood-2006-09-045625
- Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004;75:163-89. https://doi.org/10.1189/jlb.0603252
- Yoshikawa N, Mori S, Tokoro T, Ikehara S, Kumazawa H, Yamashita T, et al. IFN-gamma has a protective role against thyroid-specific autoantibody production in severe combined immunodeficient (SCID) mice xenografted with Graves' thyroid tissue. Thyroid 1996; 6:437-43. https://doi.org/10.1089/thy.1996.6.437
- Nishikawa T, Yamashita S, Namba H, Usa T, Tominaga T, Kimura H, et al. Interferon-gamma inhibition of human thyrotropin receptor gene expression. J Clin Endocrinol Metab 1993;77:1084-9.
피인용 문헌
- Graves’ disease following allogenic hematopoietic stem cell transplantation for severe aplastic anemia: case report and literature review vol.31, pp.5, 2015, https://doi.org/10.1515/jpem-2017-0358